Research and development, production and prototyping. We provide quick responses that match customer needs.
Sapara Corporation is a company based in Hyderabad, India, that conducts contract research, contract manufacturing, and contract analysis of organic substances. With a research system equipped with various instruments and facilities, we ensure thorough quality control, and our creative and innovative technical team responds sincerely. Additionally, Sapara Corporation's business areas cover a wide range, including nucleic acid-related compounds, fluorescent dyes, and carbohydrate chemistry. 【Features】 ■ Trusted worldwide for "contract research, contract manufacturing, and contract analysis" achievements ■ A research system equipped with various instruments and facilities ■ Thorough quality control and sincere responses from a creative and innovative technical team ■ Strict adherence to deadlines based on planned and rigorous schedule management ■ Quick responses through agile and dynamic activities *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Business Areas of Sapara】 ■ Nucleic Acid-related Compounds ■ Drug Discovery Chemistry (Research Support, Accumulated Experience) ■ Functional Materials ■ Chiral Technology ■ Heterocyclic Compounds ■ Microwave Synthesis ■ Bioenzyme Method for Modification and Synthesis ■ Lipid and PEG Chemistry ■ Carbohydrate Chemistry ■ Fluorescent Dyes *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Ayurveda is well-known, but historically, India has been significantly involved with "medicine." Sapala Organics was established in 2005 in Hyderabad, located in the central part of the Deccan Plateau. The state government is actively investing to make this area a "Pharma City" (a treasure trove of medicine). Sapala has gained recognition from major pharmaceutical companies in the United States and Europe, steadily achieving results. To further provide the technological capabilities developed globally to Japan, Sapala Corporation was established in February 2018 as a local subsidiary in Japan. Recently, the Japanese government has also been focusing on projects that promote advanced pharmaceutical development and drug discovery, including nucleic acid-related drugs. We encourage you to consider the technological expertise of "Sapala," which excels in these fields.
![[Market Report] Guanylic Acid Market](https://image.mono.ipros.com/public/product/image/9f4/2001182301/IPROS68027143767856426998.jpeg?w=280&h=280)
